School of Nursing, University of Wisconsin at Madison, Madison, WI, USA.
J Am Geriatr Soc. 2010 Jul;58(7):1233-40. doi: 10.1111/j.1532-5415.2010.02760.x.
To determine whether a disease-specific planning process can improve surrogate understanding of goals of patients with life-limiting illnesses for future medical treatments.
A multisite randomized controlled trial conducted between January 1, 2004 and July 31, 2007.
Six outpatient clinics of large community or university health systems in three Wisconsin cities.
Competent, English-speaking adults aged 18 and older with chronic congestive heart failure or chronic renal disease and their surrogate decision-makers.
Trained health professionals conducted a structured, patient-centered interview intended to promote informed decision-making and to result in the completion of a document clarifying the goals of the patient with regard to four disease-specific health outcome situations and the degree of decision-making latitude granted to the surrogate.
Surrogate understanding of patient goals for care with regard to four expected, disease-specific outcomes situations and of the degree of surrogate latitude in decision-making.
Three hundred thirteen patient-surrogate pairs completed the study. As measured according to kappa scores and in all four situations and in the degree of latitude, intervention group surrogates demonstrated a significantly higher degree of understanding of patient goals than control group surrogates. Intervention group kappa scores ranged from 0.61 to 0.78, whereas control group kappa scores ranged from 0.07 to 0.28.
Surrogates in the intervention group had a significantly better understanding of patient goals and preferences than surrogates in the control group. This finding is the first step toward ensuring that patient goals for care are known and honored.
确定特定疾病的规划过程是否可以提高代理人对患有绝症的患者未来医疗治疗目标的理解。
2004 年 1 月 1 日至 2007 年 7 月 31 日进行的多地点随机对照试验。
威斯康星州三个城市的六个大型社区或大学卫生系统的门诊诊所。
有能力、讲英语、年龄在 18 岁及以上的慢性充血性心力衰竭或慢性肾脏疾病患者及其代理人。
经过培训的卫生专业人员进行了一项结构化的、以患者为中心的访谈,旨在促进知情决策,并完成一份文件,阐明患者在四个特定疾病的健康结果情况下的治疗目标以及代理人在决策中的自由度。
代理人对患者在四个预期的特定疾病结果情况下的护理目标的理解程度,以及代理人在决策中的自由度。
313 对患者-代理人对完成了研究。根据 Kappa 评分和所有四个情况以及决策自由度的评分,干预组代理人对患者目标的理解程度明显高于对照组代理人。干预组的 Kappa 评分范围为 0.61 至 0.78,而对照组的 Kappa 评分范围为 0.07 至 0.28。
干预组的代理人对患者的目标和偏好的理解明显优于对照组的代理人。这一发现是确保患者的护理目标被了解和尊重的第一步。